Difference between revisions of "Ranimustine (Cymerin)"
Jump to navigation
Jump to search
Warner-admin (talk | contribs) m (Text replacement - "Adult T-cell leukemia-lymphoma" to "Adult T-cell leukemia/lymphoma") |
Warner-admin (talk | contribs) m (Text replacement - "Adult T-cell leukemia/lymphoma" to "Adult T-cell leukemia-lymphoma") |
||
| Line 3: | Line 3: | ||
==Diseases for which it used== | ==Diseases for which it used== | ||
| − | *[[Adult T-cell leukemia | + | *[[Adult T-cell leukemia-lymphoma]] |
==Also known as== | ==Also known as== | ||
Revision as of 16:22, 23 November 2019
Mechanism of action
From the NCI Drug Dictionary: A chloroethylnitrosourea derivative that inhibits proliferation and growth of tumor cells by alkylation and cross-linkage of DNA strands of tumor cells.
Diseases for which it used
Also known as
- Generic name: MCNU, ranomustine
- Brand names: Cymer, Cymerin